Estrogen receptor-binding fragment-associated gene 9 expression and its clinical significance in human testicular cancer

International Journal of Urology

Volumn 16, Issue 3, 2009, Pages 329-332

  Fujimura, Tetsuya ^b   Takahashi, Satoru ^a   Urano, Tomohiko ^b   Xiaoqiang, Liu ^d   Ogushi, Tetsuo ^b   Muramatsu, Masami ^c   Ouchi, Yasuyoshi ^b   Kitamura, Tadaichi ^b   Homma, Yukio ^b   Inoue, Satoshi ^b,c  

^a NIHON UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

^d TIANJIN HOSPITAL   (China)

Author keywords

Estrogen receptor binding fragment associated gene 9; Prognosis; Testicular cancer

Indexed keywords

ANTIBODY; ESTROGEN BINDING PROTEIN; LACTATE DEHYDROGENASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOPLASM; ESTROGEN RECEPTOR BINDING FRAGMENT ASSOCIATED GENE 9; GENE; GENE EXPRESSION; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; TESTIS; TESTIS CANCER;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIGENS, NEOPLASM; COHORT STUDIES; FROZEN SECTIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; ORCHIECTOMY; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 62149139688     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02233.x     Document Type: Article

References (20)

1. Houldworth J, Korkola JE, Bosl GJ, Chaganti RSK. Biology and genetics of adult male germ cell tumors. J. Clin. Oncol. 2006 24 : 5512 18.
2. Albers P, Albrecht W, Algaba F et al. Guidelines on testicular cancer. Eur. Urol. 2005 48 : 885 94.
3. Heidenreich A, Srivastava S, Moul JW, Hofmann R. Molecular genetic parameters in pathogenesis and prognosis of testicular germ cell tumors. Eur. Urol. 2000 37 : 121 35.
4. Watanabe T, Inoue S, Hiroi H, Orimo A, Kawashima H, Muramatsu M. Isolation of estrogen-responsive genes with a CpG island library. Mol. Cell. Biol. 1998 18 : 442 9.
5. Ikeda K, Sato M, Tsutsumi O et al. Promoter analysis and chromosomal mapping of human EBAG9 gene. Bichem. Biophys. Res. Commun. 2000 273 : 654 60.
6. Tsuchiya F, Ikeda K, Tsutsumi O et al. Molecular cloning and characterization of mouse EBAG9, homolog of a human cancer associated surface antigen: expression and regulation by estrogen. Bichem. Biophys. Res. Commun. 2001 284 : 2 10.
7. Suzuki T, Inoue S, Kawabata W et al. EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions. Br. J. Cancer 2001 85 : 1731 7.
8. Tsuneizumi M, Emi M, Nagai H et al. Overrepresentation of the EBAG9 gene at 8q23 associated with early-stage breast cancers. Clin. Cancer Res. 2001 7 : 3526 32.
9. Takahashi S, Urano T, Tsuchiya F et al. EBAG9/RCAS1 expression and its prognostic significance in prostatic cancer. Int. J. Cancer 2003 106 : 310 15.
10. Aoki T, Inoue S, Imamura H et al. EBAG9/RCAS1 expression in hepatocellular carcinoma: correlation with tumour differentiation and proliferation. Eur. J. Cancer 2003 39 : 1552 61.
11. Ji A, Aoki M, Suzuki T et al. Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer. Br. J. Cancer 2004 90 : 2197 202.
12. Ogushi T, Takahashi S, Takeuchi T et al. Estrogen receptor-binding fragment-associated antigen 9 is a tumor-promoting and prognostic factor for renal cell carcinoma. Cancer Res. 2005 65 : 3700 6.
13. International Germ Cell Cancer Collaborative Group. International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. J. Clin. Oncol. 1997 15 : 594 603.
14. Venkitaraman R, Johnson B, Huddart RA, Parker CC, Horwich A, Dearnaley DP. The utility of lactate dehydrogenase in the follow-up of testicular germ cell tumors. BJU Int. 2007 100 : 30 2.
15. Sonoda K, Nakashima M, Kaku T, Kamura T, Nakano H, Watanabe T. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer 1996 77 : 1501 9.
16. Nakashima M, Sonoda K, Watanabe T. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat. Med. 1999 5 : 938 42.
17. Engelsberg A, Hermosilla R, Karsten U, Schulein R, Dorken B, Rehm A. The Golgi protein RCAS1 controls cell surface expression of tumor-associated O-linked glycan antigens. J. Biol. Chem. 2003 278 : 22998 3007.
18. Reimer TA, Anagnostopoulos I, Erdmann B et al. Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker. BMC Cancer 2005 5 : 47.
19. Hara I, Miyake H, Yamada Y, Takenaka A, Masato F. High-dose chemotherapy for male germ cell tumor. Int. J. Urol. 2006 13 : 1037 44.
20. Alberts P, Melchior D, Muller SC. Surgery in metastatic testicular cancer. Eur. Urol. 2003 44 : 233 44.